Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.

NCT00681850 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00681850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00681850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
January 31, 2010
Enrollment
4,027 (actual)
Sites
252

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes